INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol

NCT03152149 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Tiotropium & olodaterol
DRUG: fluticasone furoate & vilanterol

Sponsor

University of Dundee

Collaborators

[object Object]
[object Object]